North America Non-Invasive Neurostimulation Devices Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033
The North America non-invasive neurostimulation devices market size is expected to reach US$ 1,906.7 million by 2033 from US$ 670.1 million in 2025. The market is estimated to register a CAGR of 14.0% from 2026 to 2033.
Report Coverage
- Product Type: Transcranial Magnetic Stimulation Devices, Transcranial Direct Current Stimulation Devices, Transcranial Ultrasound Stimulation Devices, Other Product Types
- Application: Pain & Sensory Modulation, Functional Disorders, Cognitive & Behavioral Regulation, Other Applications
- End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
US$ 670.1 Mn
Market size in 2025
US$ 1,906.7 Mn
Market Size by 2033
14.0%
CAGR, 2026 - 2033
2026-2033
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Non-Invasive Neurostimulation Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Non-Invasive Neurostimulation Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Non-Invasive Neurostimulation Devices Market Regional Analysis
6.2 North America Non-Invasive Neurostimulation Devices Market Revenue 2022-2033 (US$ Million)
6.3 North America Non-Invasive Neurostimulation Devices Market Forecast Analysis
7. North America Non-Invasive Neurostimulation Devices Market Analysis – by Product Type
7.1 Transcranial Magnetic Stimulation Devices
- 7.1.1 Overview
- 7.1.2 Transcranial Magnetic Stimulation Devices: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.2 Transcranial Direct Current Stimulation Devices
- 7.2.1 Overview
- 7.2.2 Transcranial Direct Current Stimulation Devices: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.3 Transcranial Ultrasound Stimulation Devices
- 7.3.1 Overview
- 7.3.2 Transcranial Ultrasound Stimulation Devices: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.4 Other Product Types
- 7.4.1 Overview
- 7.4.2 Other Product Types: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8. North America Non-Invasive Neurostimulation Devices Market Analysis – by Application
8.1 Pain & Sensory Modulation
- 8.1.1 Overview
- 8.1.2 Pain & Sensory Modulation: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.2 Functional Disorders
- 8.2.1 Overview
- 8.2.2 Functional Disorders: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.3 Cognitive & Behavioral Regulation
- 8.3.1 Overview
- 8.3.2 Cognitive & Behavioral Regulation: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.4 Other Applications
- 8.4.1 Overview
- 8.4.2 Other Applications: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9. North America Non-Invasive Neurostimulation Devices Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other End Users: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
10. North America Non-Invasive Neurostimulation Devices Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Non-Invasive Neurostimulation Devices Market Breakdown, by Key Country, 2026 and 2033 (%)
- 10.2.1.1 North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.1.1 US: North America Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.1.2 US: North America Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.1.3 US: North America Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.2 Canada: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.2.1 Canada: North America Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.2.2 Canada: North America Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.3 Mexico: North America Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.3.1 Mexico: North America Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.3.2 Mexico: North America Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.3.3 Mexico: North America Non-Invasive Neurostimulation Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 ONWARD Medical N.V.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 eNeura Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Neuronetics
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BrainsWay Ltd.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Soterix Medical Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Flow Neuroscience
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Magstim
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Nexstim
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Neurosoft
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Remed
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.